These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 5340893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacologic study of a cholinomimetic derived from oxazolidinone].
    Allain P, Frossard J, Weber A, Chareton JY.
    Therapie; 1969; 24(6):1027-41. PubMed ID: 5367183
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in cholinergic agonist- and cholinergic antagonist-induced changes in avoidance responses between dd mice and Wistar rats.
    Kuribara H, Tadokoro S.
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):159-66. PubMed ID: 6678530
    [Abstract] [Full Text] [Related]

  • 8. On certain correlations between cholinergic blocking drugs, convulsive excitability of the central nervous system and the anticonvulsive acitivity of the anticonvulsants.
    Roussinov KS.
    Izv Inst Fiziol (Sofiia); 1968 Dec; 11():169-77. PubMed ID: 5684380
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacology of central cholinergic synapse].
    Decombe R, Bentué-Ferrer D, Van den Driessche J, Allain H.
    Rev Med Interne; 1988 Dec; 9(3):314-20. PubMed ID: 2841740
    [Abstract] [Full Text] [Related]

  • 10. [The role of cholinergic processes in the synaptic transmission in the brain cortex].
    Vinogradova VM.
    Dokl Akad Nauk SSSR; 1967 Jul 11; 175(2):491-4. PubMed ID: 4315704
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacology of the central nervous system.
    Norton S, Walaszek EJ.
    Prog Neurol Psychiatry; 1967 Jul 11; 22():121-45. PubMed ID: 4972194
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cholinergic and non-cholinergic pharmacology of the bronchioles.
    Koelle GB.
    Postgrad Med J; 1975 Jul 11; 51(7 SUPPL):63-8. PubMed ID: 1232604
    [No Abstract] [Full Text] [Related]

  • 16. [Muscarinic receptors].
    Heinzl S.
    Med Monatsschr Pharm; 1988 Nov 11; 11(11):359-60. PubMed ID: 3200219
    [No Abstract] [Full Text] [Related]

  • 17. [Electroencephalographic analysis of the central action of phenacon].
    Toreva DK.
    Farmakol Toksikol; 1968 Nov 11; 31(1):5-8. PubMed ID: 5675349
    [No Abstract] [Full Text] [Related]

  • 18. [On the pharmacology of 2,3-dioxybenzoic acid].
    Polukordas G, Repchite M, Skublitskene G.
    Farmakol Toksikol; 1966 Nov 11; 29(5):594-7. PubMed ID: 5995071
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of central m- and n-cholinergic agents on ovarian compensatory hypertrophy in rats].
    Anisimov VN.
    Probl Endokrinol (Mosk); 1978 Nov 11; 24(5):85-7. PubMed ID: 704564
    [Abstract] [Full Text] [Related]

  • 20. [Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines].
    Longo VG.
    Actual Neurophysiol (Paris); 1967 Nov 11; 7():203-16. PubMed ID: 6043096
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.